Clinical trials
Phase 1 Idiopathic Pulmonary Fibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
101 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 6 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 6 |
| 2020 | 6 |
| 2021 | 13 |
| 2022 | 9 |
| 2023 | 13 |
| 2024 | 11 |
| 2025 | 5 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 71 |
| Terminated | 8 |
| Unknown status | 7 |
| Recruiting | 6 |
| Not yet recruiting | 6 |
| Active, not recruiting | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 6 |
| Sunshine Lake Pharma Co., Ltd. | 5 |
| Bristol-Myers Squibb | 4 |
| AstraZeneca | 3 |
| Daewoong Pharmaceutical Co. LTD. | 3 |
| Hal Chapman | 3 |
| Overseas Pharmaceuticals, Ltd. | 3 |
| Chiesi Farmaceutici S.p.A. | 2 |
| Endeavor Biomedicines, Inc. | 2 |
| Guangdong Hengrui Pharmaceutical Co., Ltd | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Idiopathic Pulmonary Fibrosis | 101 |
| Pulmonary Fibrosis | 11 |
| Fibrosis | 5 |
| Lung Diseases | 4 |
| Lung Diseases, Interstitial | 4 |
| Pulmonary Disease, Chronic Obstructive | 3 |
| Hypertension, Pulmonary | 2 |
| Idiopathic Interstitial Pneumonias | 2 |
| Respiratory Tract Diseases | 2 |
| Asthma | 1 |
Trials
Showing 76 to 100 of 101. Each trial links to its page on Pharma Observatory.
1 more trial matches. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.